1. Home
  2. SNSE vs REBN Comparison

SNSE vs REBN Comparison

Compare SNSE & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • REBN
  • Stock Information
  • Founded
  • SNSE 2005
  • REBN 2015
  • Country
  • SNSE United States
  • REBN United States
  • Employees
  • SNSE N/A
  • REBN N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • SNSE Health Care
  • REBN Consumer Discretionary
  • Exchange
  • SNSE Nasdaq
  • REBN Nasdaq
  • Market Cap
  • SNSE 14.5M
  • REBN 15.3M
  • IPO Year
  • SNSE 2021
  • REBN 2022
  • Fundamental
  • Price
  • SNSE $11.71
  • REBN $2.11
  • Analyst Decision
  • SNSE Strong Buy
  • REBN
  • Analyst Count
  • SNSE 4
  • REBN 0
  • Target Price
  • SNSE $72.50
  • REBN N/A
  • AVG Volume (30 Days)
  • SNSE 56.5K
  • REBN 48.6K
  • Earning Date
  • SNSE 11-13-2025
  • REBN 11-18-2025
  • Dividend Yield
  • SNSE N/A
  • REBN N/A
  • EPS Growth
  • SNSE N/A
  • REBN N/A
  • EPS
  • SNSE N/A
  • REBN N/A
  • Revenue
  • SNSE N/A
  • REBN $6,565,623.00
  • Revenue This Year
  • SNSE N/A
  • REBN $335.98
  • Revenue Next Year
  • SNSE N/A
  • REBN N/A
  • P/E Ratio
  • SNSE N/A
  • REBN N/A
  • Revenue Growth
  • SNSE N/A
  • REBN 14.03
  • 52 Week Low
  • SNSE $5.00
  • REBN $1.03
  • 52 Week High
  • SNSE $18.35
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 53.46
  • REBN 26.66
  • Support Level
  • SNSE $11.00
  • REBN $2.28
  • Resistance Level
  • SNSE $18.35
  • REBN $2.46
  • Average True Range (ATR)
  • SNSE 1.55
  • REBN 0.10
  • MACD
  • SNSE 0.36
  • REBN -0.03
  • Stochastic Oscillator
  • SNSE 27.83
  • REBN 3.64

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: